Hard to figure sometimes. Taug has stayed alive and basically came back from the dead while staying current in filings.
2021 could be make or break year. While I love the retail gum and it's brand is definitely growing if 2021 is going have success I look to Vistagen appreciation and the pharma trial.
If TAUG can show good results in the pharma trial, which should be a fairly easy trial to implement, a $20, $50 $100 million market cap could be low.
It is a penny stock, and penny stocks TAUG is a risk / reward company. Some people think it is worth rolling the dice and some don't.